| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $131,229,810 ) (Continued on the next page) |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI148747 | An Integrated Multilevel Modeling Framework for Repertoire-Based Diagnostics | 001 | 4 | NIH | 8/31/2023 | $182,295 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K08DK123400 | Novel signaling pathways in the ciliary inversin compartment | 006 | 4 | NIH | 8/4/2023 | -$164,484 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG065554 | Scheduled Prophylactic 6-hourly IV Acetaminophen to Prevent Postoperative Delirium in Older Cardiac Surgical Patients | 000 | 4 | NIH | 1/6/2023 | $1,633,157 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK121889 | Identification of unique nitric oxide-expressing hematopoietic stem cells and their special vascular niche | 000 | 4 | NIH | 1/27/2023 | $459,692 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | DP5OD028129 | Functional genetics of tissue factor in bleeding and thrombotic risk | 001 | 5 | NIH | 8/22/2023 | $437,499 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG079799 | Molecular mechanisms of aging and accelerated aging in the human brain | 000 | 1 | NIH | 9/13/2023 | $841,971 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | U24HL166784 | 2/2: PREcision VENTilation to attenuate Ventilation-Induced Lung Injury (PREVENT VILI) | 000 | 1 | NIH | 8/23/2023 | $1,175,434 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | F32DK135247 | Functional mapping of the parabrachial nucleus: from gastrointestinal topography to satiety | 001 | 1 | NIH | 12/14/2022 | $0 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21MH127479 | What the Nose Knows: Hedonic Capacity, Psychosocial Interventions and Outcomes in Schizophrenia | 000 | 2 | NIH | 3/13/2023 | $151,250 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS129156 | Minimally Invasive Tissues Sampling to Evaluate HIV-associated Meningitis in Zambia | 000 | 2 | NIH | 4/13/2023 | $10,000 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21CA267088 | Admin Suppl Gender-affirming estrogen therapy and breast cancer treatment outcome | 002 | 2 | NIH | 9/14/2023 | $89,920 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21CA267088 | Admin Suppl Gender-affirming estrogen therapy and breast cancer treatment outcome | 001 | 2 | NIH | 3/22/2023 | $16,363 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 001 | 3 | NIH | 5/11/2023 | $0 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 001 | 3 | NIH | 5/11/2023 | $0 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA262536 | Prostate Cancer Vulnerabilities to BH3 Mimetic Drugs | 000 | 3 | NIH | 5/22/2023 | $392,306 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL157530 | A Multi-Dimensional Linked Registry to Identify Biological, Clinical, Health System, and Socioeconomic Risk Factors for COVID-19-Related Cardiovascular Events | 001 | 3 | NIH | 4/3/2023 | $865,807 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL154744 | Gadolinium Free Cardiac MR Imaging of Scar and Fibrosis | 000 | 4 | NIH | 8/9/2023 | $860,262 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AR075964 | Predicting Fracture Risk in Patients Treated with Radiotherapy for Spinal Metastatic Disease | 000 | 4 | NIH | 3/24/2023 | $681,073 |
| | 2023 | 2023 | Beth Israel Deaconess Medical Center, Inc | 330 Brookline Ave | Boston | MA | 02215-5400 | SUFFOLK | USA | NU2GGH002212 | Strengthening Vietnam's HIV Technical Assistance Capacity | 04 | 4 | CDC | 4/17/2023 | $0 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R56CA284564 | Gender-Affirming Testosterone Therapy on Breast Cancer Risk and Treatment Outcomes | 000 | 1 | NIH | 9/18/2023 | $299,940 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K01DK131347 | Role of hypothalamic IRF3 transcriptional dysregulation in obesity | 000 | 1 | NIH | 8/25/2023 | $150,736 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI178875 | Susceptibility and resistance of multidrug-resistant gram-negative bacteria to novel beta-lactam/beta-lactamase inhibitor combinations | 000 | 1 | NIH | 8/4/2023 | $484,436 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R03NS128993 | The Role of Neurotensin-Expressing Neurons of the Extended Ventrolateral Preoptic Nucleus in REM Sleep Regulation | 000 | 1 | NIH | 2/2/2023 | $86,450 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01NS129156 | Minimally Invasive Tissues Sampling to Evaluate HIV-associated Meningitis in Zambia | 000 | 2 | NIH | 4/13/2023 | $725,436 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA266704 | Enhancing the Efficacy of Docetaxel in Prostate Cancer | 000 | 2 | NIH | 7/24/2023 | $641,446 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21CA267088 | Admin Suppl Gender-affirming estrogen therapy and breast cancer treatment outcome | 000 | 2 | NIH | 11/22/2022 | $184,079 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK132284 | Structure-Guided Design of Intestine-Selective AHR Agonists for Restoration of Gut Barrier Integrity in IBD | 000 | 2 | NIH | 3/17/2023 | $705,947 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 001 | 3 | NIH | 5/11/2023 | $0 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 001 | 3 | NIH | 5/11/2023 | $0 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AI157208 | Use of De Novo Synthesis Approaches and Structure-guided Design to Optimize Therapeutic Properties of Streptothricin Class Antimicrobials | 000 | 4 | NIH | 8/15/2023 | $766,825 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K24HL153669 | Mentoring in Patient-Oriented and Translational HFpEF Research | 000 | 5 | NIH | 6/9/2023 | $121,948 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA241194 | Targeting microRNAs in the tumor microenvironment with pHLIP conjugated next generation chemically modified PNAs | 000 | 4 | NIH | 1/25/2023 | $376,615 |
| | 2023 | 2023 | Beth Israel Deaconess Medical Center, Inc | 330 Brookline Ave | Boston | MA | 02215-5400 | SUFFOLK | USA | NU2GGH002212 | Strengthening Vietnam's HIV Technical Assistance Capacity | 02 | 4 | CDC | 3/6/2023 | $646,958 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21EB032932 | High-Resolution Lymphatic Mapping of the Upper Extremities with MRI | 000 | 1 | NIH | 4/24/2023 | $216,125 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01CA271601 | Understanding the cellular and functional changes in the immune tumor microenvironment of glioblastoma during progression and treatments. | 000 | 1 | NIH | 4/17/2023 | $672,634 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01AG082093 | Non-coding RNAs in resilience to Alzheimer?s Disease | 000 | 1 | NIH | 5/4/2023 | $862,503 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K99DK134853 | Competing effects of AgRP and POMC neurons on cAMP signaling in downstream neurons in vivo | 001 | 1 | NIH | 3/27/2023 | $0 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23MH127464 | The Impact of Insufficient Sleep and Insomnia Disorder on Behavioral and Neural Markers of Emotion Regulation | 000 | 2 | NIH | 5/23/2023 | $147,209 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL161385 | Using Machine Learning to find a life saving needle in a haystack of children's emergencies | 001 | 2 | NIH | 8/4/2023 | $608,819 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 001 | 3 | NIH | 5/11/2023 | $0 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UM1AI164556 | I4C 2.0: Immunotherapy for Cure | 000 | 3 | NIH | 4/21/2023 | $166,667 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | UG3NS130592 | Sensory Phenotyping to Enhance Neuropathic Pain Drug Development | 000 | 1 | NIH | 9/21/2023 | $1,600,475 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R21EY035436 | Multiplexed Sensing and Control of Neuromodulators and Peptides in the Awake Brain | 000 | 1 | NIH | 8/30/2023 | $259,350 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | F32DK135247 | Functional mapping of the parabrachial nucleus: from gastrointestinal topography to satiety | 002 | 1 | NIH | 2/10/2023 | $1,918 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01HL161253 | Data-Driven Sleep Biomarkers of Brain Health, Heart Health, and Mortality | 002 | 3 | NIH | 9/13/2023 | $2,188,717 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK128406 | The role of interferon regulatory factors in tanycytes during HFD-induced inflammation, obesity and glucose dysregulation | 000 | 2 | NIH | 2/27/2023 | $551,046 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | K23AG068364 | Understanding the structural, functional, and prognostic implications of cortical excitability in Alzheimer's disease | 000 | 3 | NIH | 5/11/2023 | $165,020 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | R01DK125846 | Characterizing the role of the heme catabolism in tissue damage and inflammation. | 000 | 3 | NIH | 3/3/2023 | $523,605 |
| | 2023 | 2023 | BETH ISRAEL DEACONESS MEDICAL CENTER, INC | 330 BROOKLINE AVE | BOSTON | MA | 02215-5400 | SUFFOLK | USA | T32HL155020 | Training Program in Resuscitation Science | 001 | 3 | NIH | 2/22/2023 | $13,478 |
|
